[Updated September 18, 2025, 07:00 AM PST]: The date and time of the presentation have been revised from what was originally issued. Please refer to the updated details below. SANTA ANA, Calif., Sept. 18, 2025 – NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and […] The post NKGen Biotech to Present on the Use of Troculeucel for Neurodegenerative Diseases at the 3rd China Great Bay Cell and Gene Ther...
